TEVA


Company Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Sells Off Last of Specialty Global Women’s Health Portfolio Assets in $1.38 Billion Deal

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is saying goodbye to its remaining global women’s health business assets in exchange for $1.38 billion.

Is New Teva Pharmaceutical Industries Ltd (ADR) (TEVA) CEO Walking into a Landmine? Oppenheimer and Maxim Weigh In

Here’s why analysts are playing it cautiously optimistic on the struggling pharmaceutical giant.

Cantor Believes Teva Pharmaceutical Industries Ltr (ADR) New CEO Will Unlock Value for Shares

Analyst Louise Chen cheers that new Danish CEO means “good news” for Tesla investors.

Hedge Fund Guru Efrem Kamen Pulled Cash From Otonomy Inc (OTIC) and Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Welcoming Gilead Sciences, Inc. (GILD)

How Do Biotech’s Movers and Shakers Fare Under Puravida Funds’ Healthcare-Centric Trading Strategy?

Teva Pharmaceutical Industries Ltd’s (ADR) (TEVA) AUSTEDO Wins Key FDA Approval To Corner TD Market

TEVA’s Brand Drug Portfolio and Pipeline Are Undervalued, Says Analyst

Company Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Announces FDA Approval of AUSTEDO for the Treatment of Tardive Dyskinesia in Adults

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that the FDA has approved AUSTEDO (deutetrabenazine) tablets for the treatment of tardive dyskinesia in adults. AUSTEDO®was …

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Lacking Leadership and Strategy; Credit Suisse Downgrades to Underperform

TEVA Core Challenges Aren’t Going To Fade Anytime Soon, Says Analyst

Valeant Pharmaceuticals Intl Inc (VRX) Moves Forward as cGMP Concerns Resolved, Teva Pharmaceutical Industries Ltd’s (ADR) (TEVA) Price Target Slashed at Mizuho

Two Pharmaceutical Companies that Have Recently Found Themselves in Hot Water Look for Relief

Teva Pharmaceutical Industries Ltd (ADR) (TEVE) Announces Exclusive Launch of Generic Axiron® in the United States

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced the launch of generic Axiron®1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the U.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts